The aim of this tutorial is to teach and update the participants on biology, diagnostic and treatment options of chronic myeloid malignancies.

Participants of the EHA Hematology Tutorial will be able to gain insight in:

• new WHO 2016 classification of myeloid malignancies
• new prognostic classifications, including the latest knowledge about the role of mutations affecting epigenetics and splicing in MDS and MPNs phenotype and evolution
• the place of generic drugs and treatment discontinuation in CML
• the role of allogeneic transplantation in these diseases
• the optimal management of blastic transformation